Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BMN 111 in children with Achondroplasia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• BMN-111 (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Achondroplasia | Phase 3 | Status: COMPLETED | Results posted: 2022-03-02